Risperidone Augmentation for Treatment-Resistant Aggression in ADHD

NCT00297739 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

INDIV

Sponsor class

Conditions

Aggression

Interventions

DRUG: Risperidone

Sponsor

Armenteros, Jorge L., M.D., P.A.

Collaborators

[object Object]